Science Explorer Back to mapMap
Discussion
Researcher · Q Therapeutics (United States) · United States

Erica R. Tobin

Erica R. Tobin publishes mostly in Oncology, Molecular Biology and Cancer Research, on topics such as DNA Repair Mechanisms, PARP inhibition in cancer therapy and CRISPR and Genetic Engineering.

ORCID 0009-0009-0056-5224 OpenAlex
World rank
#1,484,975
of 7,710,434 ranked researchers
Rank in United States
#466,055
of 1,627,098
Works
109
Citations
1.2k
Citations per work
11.1
h-index
8
i10-index 8Top 72% in Oncology
Erica R. Tobin

What does Erica R. Tobin research?

Erica R. Tobin's work is mostly in Biochemistry, Genetics and Molecular Biology (42%), Medicine (40%).

Life Sciences: 46 works · 42.2% of their workBiochemistry, Genetics and Molecular Biology: 46 works · 42.2% of their workMolecular Biology: 31 works · 28.1% of their workCancer Research: 10 works · 8.8% of their workGenetics: 6 works · 5.3% of their workHealth Sciences: 44 works · 40.4% of their workMedicine: 44 works · 40.4% of their workOncology: 31 works · 28.1% of their workHematology: 8 works · 7.0% of their workGenetics: 6 works · 5.3% of their workEverything else: 19 works · 17.4% of their workTHEIR WORKErica R. Tobin109works
Life Sciences42%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4642.2%
    1. Medicine4440.4%
  3. Everything else1917.4%
  1. 1Oncology28% of their works
  2. 2Molecular Biology28% of their works
  3. 3Cancer Research9% of their works
  4. 4Hematology7% of their works
  5. 5Genetics5% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Erica R. Tobin's research?

The keywords of their largest research topics: Homologous Recombination, Genomic Instability, DNA Damage, Repair, BRCA Mutation, PARP Inhibitors, Genome Engineering and RNA-Guided.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Homologous Recombination132 topics
  2. Genomic Instability92 topics
  3. DNA Damage71 topic
  4. Repair71 topic
  5. BRCA Mutation61 topic
  6. PARP Inhibitors61 topic
  7. Genome Engineering51 topic
  8. RNA-Guided51 topic
  9. AML41 topic
  10. Acute Myeloid Leukemia41 topic
  11. CAR T Cells31 topic
  12. Chimeric Antigen Receptor31 topic
  13. Fc Receptors31 topic
  14. HIF-131 topic
  15. Therapeutic Antibodies31 topic
  16. Warburg Effect31 topic
  17. Cancer Genomics21 topic
  18. Mutational Signatures21 topic

Where does Erica R. Tobin work?

Erica R. Tobin's main affiliation in the publication record is Q Therapeutics (United States), United States.

How many publications and citations does Erica R. Tobin have?

OpenAlex counts 109 works and 1,210 citations for Erica R. Tobin, an h-index of 8, ranking #1,484,975 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Erica R. Tobin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.